Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Phase 1 BAFF CAR T clinical trial for patients with relapsed and refractory multiple myeloma underway at UH Seidman Cancer Center

University Hospitals (UH) Seidman Cancer Center hematologist-oncologist Leland Metheny, MD, is leading the trial. He says in the two years since the foundational pre-clinical work was completed, the team has shown that it's feasible to manufacture BAFF CAR T-cells for human subjects.

August 15, 2024


August 23 2024

August 22 2024

August 21 2024

August 20 2024

August 19 2024

August 18 2024

August 17 2024

August 16 2024

August 15 2024

August 14 2024

August 13 2024

August 12 2024

August 11 2024

August 10 2024

August 9 2024